エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/26 | 6,697 | 6,736 | 6,619 | 6,627 | -5 | -0.1% | 1,477,500 |
| 2024/06/25 | 6,450 | 6,632 | 6,417 | 6,632 | +143 | +2.2% | 1,223,700 |
| 2024/06/24 | 6,403 | 6,489 | 6,369 | 6,489 | +128 | +2% | 808,200 |
| 2024/06/21 | 6,254 | 6,388 | 6,254 | 6,361 | +75 | +1.2% | 1,250,800 |
| 2024/06/20 | 6,349 | 6,399 | 6,252 | 6,286 | -63 | -1% | 850,600 |
| 2024/06/19 | 6,267 | 6,359 | 6,263 | 6,349 | +54 | +0.9% | 909,600 |
| 2024/06/18 | 6,356 | 6,389 | 6,267 | 6,295 | -80 | -1.3% | 955,500 |
| 2024/06/17 | 6,260 | 6,375 | 6,230 | 6,375 | +119 | +1.9% | 1,078,200 |
| 2024/06/14 | 6,310 | 6,339 | 6,220 | 6,256 | -154 | -2.4% | 2,535,100 |
| 2024/06/13 | 6,590 | 6,616 | 6,341 | 6,410 | -173 | -2.6% | 1,660,400 |
| 2024/06/12 | 6,520 | 6,602 | 6,509 | 6,583 | -66 | -1% | 1,142,200 |
| 2024/06/11 | 6,665 | 6,705 | 6,527 | 6,649 | -223 | -3.2% | 2,969,200 |
| 2024/06/10 | 6,726 | 6,929 | 6,712 | 6,872 | +104 | +1.5% | 893,600 |
| 2024/06/07 | 6,811 | 6,837 | 6,759 | 6,768 | -114 | -1.7% | 1,146,200 |
| 2024/06/06 | 7,060 | 7,096 | 6,848 | 6,882 | -198 | -2.8% | 1,641,700 |
| 2024/06/05 | 7,000 | 7,110 | 6,998 | 7,080 | +115 | +1.7% | 2,006,600 |
| 2024/06/04 | 6,767 | 6,965 | 6,767 | 6,965 | +146 | +2.1% | 1,438,100 |
| 2024/06/03 | 6,790 | 6,825 | 6,733 | 6,819 | +66 | +1% | 910,300 |
| 2024/05/31 | 6,680 | 6,762 | 6,656 | 6,753 | +178 | +2.7% | 1,967,300 |
| 2024/05/30 | 6,598 | 6,628 | 6,432 | 6,575 | -91 | -1.4% | 1,299,700 |
| 2024/05/29 | 6,707 | 6,750 | 6,665 | 6,666 | -69 | -1% | 879,300 |
| 2024/05/28 | 6,800 | 6,830 | 6,710 | 6,735 | -46 | -0.7% | 860,300 |
| 2024/05/27 | 6,811 | 6,825 | 6,686 | 6,781 | +17 | +0.3% | 875,500 |
| 2024/05/24 | 6,649 | 6,764 | 6,624 | 6,764 | +124 | +1.9% | 1,129,600 |
| 2024/05/23 | 6,609 | 6,657 | 6,530 | 6,640 | +47 | +0.7% | 1,130,200 |
| 2024/05/22 | 6,639 | 6,707 | 6,575 | 6,593 | -46 | -0.7% | 933,000 |
| 2024/05/21 | 6,630 | 6,669 | 6,540 | 6,639 | -16 | -0.2% | 1,202,100 |
| 2024/05/20 | 6,693 | 6,712 | 6,620 | 6,655 | -124 | -1.8% | 1,468,900 |
| 2024/05/17 | 6,793 | 6,801 | 6,646 | 6,779 | -87 | -1.3% | 1,426,000 |
| 2024/05/16 | 6,940 | 7,077 | 6,828 | 6,866 | +2 | ±0% | 2,516,400 |
| 2024/05/15 | 6,850 | 6,974 | 6,684 | 6,864 | +17 | +0.2% | 3,523,300 |
| 2024/05/14 | 6,793 | 6,886 | 6,749 | 6,847 | +83 | +1.2% | 1,234,200 |
| 2024/05/13 | 6,775 | 6,786 | 6,699 | 6,764 | -29 | -0.4% | 985,000 |
| 2024/05/10 | 6,730 | 6,807 | 6,703 | 6,793 | +104 | +1.6% | 1,269,100 |
| 2024/05/09 | 6,640 | 6,761 | 6,640 | 6,689 | +79 | +1.2% | 1,424,900 |
| 2024/05/08 | 6,557 | 6,648 | 6,525 | 6,610 | +15 | +0.2% | 1,097,400 |
| 2024/05/07 | 6,600 | 6,621 | 6,515 | 6,595 | +50 | +0.8% | 1,653,700 |
| 2024/05/02 | 6,540 | 6,554 | 6,472 | 6,545 | -4 | -0.1% | 995,400 |
| 2024/05/01 | 6,472 | 6,607 | 6,411 | 6,549 | +47 | +0.7% | 1,404,000 |
| 2024/04/30 | 6,309 | 6,515 | 6,267 | 6,502 | +262 | +4.2% | 2,085,800 |
| 2024/04/26 | 6,200 | 6,248 | 6,136 | 6,240 | -19 | -0.3% | 1,179,200 |
| 2024/04/25 | 6,250 | 6,333 | 6,176 | 6,259 | +170 | +2.8% | 2,587,700 |
| 2024/04/24 | 6,117 | 6,173 | 6,047 | 6,089 | -1 | ±0% | 1,168,700 |
| 2024/04/23 | 6,150 | 6,160 | 6,043 | 6,090 | -2 | ±0% | 641,600 |
| 2024/04/22 | 5,969 | 6,098 | 5,923 | 6,092 | +191 | +3.2% | 1,002,400 |
| 2024/04/19 | 5,800 | 5,920 | 5,795 | 5,901 | +77 | +1.3% | 1,410,700 |
| 2024/04/18 | 5,875 | 5,913 | 5,811 | 5,824 | -80 | -1.4% | 1,118,500 |
| 2024/04/17 | 6,037 | 6,040 | 5,901 | 5,904 | -148 | -2.4% | 1,041,800 |
| 2024/04/16 | 5,950 | 6,052 | 5,928 | 6,052 | +40 | +0.7% | 797,900 |
| 2024/04/15 | 5,971 | 6,026 | 5,928 | 6,012 | -29 | -0.5% | 648,000 |
101～
150
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 461,900円 | +1.7% | -2.9% | 3.46% | 30.30倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 157,200円 | +12.2% | +180.3% | 4.71% | 56.28倍 | 1.84倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 205,900円 | +5.7% | +3.9% | 2.78% | 10.24倍 | 1.35倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 254,500円 | +11.3% | -5.4% | 2.28% | 19.59倍 | 1.54倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 174,600円 | -3.5% | -50.2% | 4.58% | 14.14倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
